CU6 0.46% $6.47 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-356

  1. 6,863 Posts.
    lightbulb Created with Sketch. 1765

    I came across and listened to this before I went to sleep and it just got me a whole lot more excited. Alan is a gifted scientist and salesman - he can weave beautiful stories, hit a “kapow!” Punch to BP at various stages of the interview and he is exposing chunks in the armour of both science and commerical opportunities with ease. I hate minute taking at work but Alan makes me want to do it, and I have listened to this interview this morning before posting now. You don’t have too many business heads let alone a “simple scientist” with such abilities.

    Keen to see when the open the lid on their box of tricks as AT is talking about combination therapies with APRI’s, IO and more. He is clearly focused not just on diagnostic but game changing therapy opportunity and pairing.

    Colorectal, Breast, Ovarian and other cancers, and non-ontological applications. Truly a great science + commercial story unfolding before us. Those worrying about SP/ MC need to look at this big picture.

    AIMO. No advice. DYOR.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.